New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
Abstract Background An effective malaria transmission-blocking vaccine (TBV) would be a major advance in the current efforts to eliminate and, ultimately, eradicate malaria. Antibodies against Plasmodium falciparum surface protein, Pfs25, are known to block parasite development in the mosquito vecto...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2017-06-01
|
| シリーズ: | Malaria Journal |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12936-017-1896-7 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|